Toby L. Simon

3.5k total citations
66 papers, 2.4k citations indexed

About

Toby L. Simon is a scholar working on Management of Technology and Innovation, Hematology and Biochemistry. According to data from OpenAlex, Toby L. Simon has authored 66 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Management of Technology and Innovation, 28 papers in Hematology and 23 papers in Biochemistry. Recurrent topics in Toby L. Simon's work include Blood donation and transfusion practices (28 papers), Blood transfusion and management (23 papers) and Hemoglobinopathies and Related Disorders (11 papers). Toby L. Simon is often cited by papers focused on Blood donation and transfusion practices (28 papers), Blood transfusion and management (23 papers) and Hemoglobinopathies and Related Disorders (11 papers). Toby L. Simon collaborates with scholars based in United States, Switzerland and Germany. Toby L. Simon's co-authors include William R. Bell, David J. Wright, Paul M. Ness, Alan E. Mast, Edward L. Murphy, Sol Sherry, James M. Stengle, Ritchard G. Cable, Joseph E. Kiss and Whitney R. Steele and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Toby L. Simon

64 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Toby L. Simon United States	27	861	823	566	545	522	66	2.4k
Brenda J. Grossman United States	21	775 0.9×	433 0.5×	1.2k 2.1×	326 0.6×	214 0.4×	60	2.4k
Yulia Lin Canada	31	911 1.1×	406 0.5×	1.3k 2.3×	379 0.7×	291 0.6×	162	2.9k
Kathryn E. Webert Canada	28	1.2k 1.3×	438 0.5×	1.1k 1.9×	324 0.6×	227 0.4×	68	2.4k
Nadine Shehata Canada	30	1.2k 1.4×	403 0.5×	812 1.4×	551 1.0×	254 0.5×	142	2.8k
Giancarlo Maria Liumbruno Italy	26	1.0k 1.2×	252 0.3×	872 1.5×	340 0.6×	320 0.6×	73	2.9k
Erik A.M. Beckers Netherlands	26	1.2k 1.4×	321 0.4×	648 1.1×	300 0.6×	172 0.3×	92	2.2k
James P. Isbister Australia	25	554 0.6×	463 0.6×	933 1.6×	224 0.4×	155 0.3×	113	2.1k
Edward L. Wallace United States	18	451 0.5×	674 0.8×	963 1.7×	187 0.3×	99 0.2×	32	1.7k
Heather Hume Canada	25	1.4k 1.7×	392 0.5×	1.3k 2.3×	739 1.4×	79 0.2×	62	3.2k
Sue Pavord United Kingdom	28	1.6k 1.9×	96 0.1×	163 0.3×	630 1.2×	267 0.5×	89	3.0k

Countries citing papers authored by Toby L. Simon

Since Specialization

Citations

This map shows the geographic impact of Toby L. Simon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toby L. Simon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toby L. Simon more than expected).

Fields of papers citing papers by Toby L. Simon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toby L. Simon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toby L. Simon. The network helps show where Toby L. Simon may publish in the future.

Co-authorship network of co-authors of Toby L. Simon

This figure shows the co-authorship network connecting the top 25 collaborators of Toby L. Simon. A scholar is included among the top collaborators of Toby L. Simon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toby L. Simon. Toby L. Simon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Becker, Mark, et al.. (2023). Why do US source plasma donors stop donating?. Transfusion. 63(10). 1904–1915. 4 indexed citations

Simon, Toby L., et al.. (2023). Review and assessment of the donor safety among plasma donors. Transfusion. 63(6). 1230–1240. 5 indexed citations

Simon, Toby L., et al.. (2022). Hyperoncotic human albumin solutions for intravenous fluid therapy: Effectiveness of pathogen safety and purification methods, and clinical safety. Biosafety and Health. 5(1). 21–29. 2 indexed citations

Barnes, Thomas W., Johannes Schulte-Pelkum, Christina Kober, et al.. (2021). Determination of neutralising anti-SARS-CoV-2 antibody half-life in COVID-19 convalescent donors. Clinical Immunology. 232. 108871–108871. 12 indexed citations

Modrof, Jens, et al.. (2017). Measles Virus Neutralizing Antibodies in Intravenous Immunoglobulins: Is an Increase by Revaccination of Plasma Donors Possible?. The Journal of Infectious Diseases. 216(8). 977–980. 8 indexed citations

Kiss, Joseph E., Whitney R. Steele, David J. Wright, et al.. (2013). Laboratory variables for assessing iron deficiency in REDS‐II Iron Status Evaluation (RISE) blood donors. Transfusion. 53(11). 2766–2775. 33 indexed citations

Custer, Brian, Karen S. Schlumpf, Toby L. Simon, et al.. (2011). Demographics of successful, unsuccessful and deferral visits at six blood centers over a 4‐year period. Transfusion. 52(4). 712–721. 39 indexed citations

Carey, Patricia M., Karen S. Schlumpf, Alan E. Mast, et al.. (2011). Donation return time at fixed and mobile donation sites. Transfusion. 52(1). 127–133. 10 indexed citations

Cable, Ritchard G., Simone A. Glynn, Joseph E. Kiss, et al.. (2010). Iron deficiency in blood donors: analysis of enrollment data from the REDS‐II Donor Iron Status Evaluation (RISE) study. Transfusion. 51(3). 511–522. 145 indexed citations

10.

Custer, Brian, Karen S. Schlumpf, David J. Wright, et al.. (2010). Donor return after temporary deferral. Transfusion. 51(6). 1188–1196. 66 indexed citations

11.

McCullough, Jeffrey, Kaaron Benson, Susan D. Roseff, et al.. (2008). Career activities of physicians taking the subspecialty board examination in blood banking/transfusion medicine. Transfusion. 48(4). 762–767. 4 indexed citations

12.

Mathew, Prasad, Toby L. Simon, Kristin E. Hunt, & Kendall P. Crookston. (2006). How we manage requests for recombinant factor VIIa (NovoSeven). Transfusion. 47(1). 8–14. 6 indexed citations

13.

Lewis, Sharon L., et al.. (1997). Effect of long-term platelet donation on lymphocyte subsets and plasma protein concentrations. Transfusion Science. 18(2). 205–213. 7 indexed citations

14.

Simon, Toby L.. (1994). The Collection of Platelets by Apheresis Procedures. Transfusion Medicine Reviews. 8(2). 132–145. 32 indexed citations

15.

Shively, Bruce K., et al.. (1990). Age-related changes cardiac in function by color Doppler echocardiography. Journal of the American College of Cardiology. 15(2). A187–A187. 1 indexed citations

16.

Simon, Toby L.. (1989). Comprehensive curricular goals for teaching transfusion medicine. Transfusion. 29(5). 438–446. 32 indexed citations

17.

Simon, Toby L. & Kenneth J. Smith. (1989). The issues in autologous transfusion. Human Pathology. 20(1). 3–6. 4 indexed citations

18.

Simon, Toby L., et al.. (1988). Posttransfusion purpura associated with alloantibody specific for the platelet antigen, Pen^a. American Journal of Hematology. 29(1). 38–40. 11 indexed citations

19.

Strauss, Ronald G., Linda C. Stehling, Rita Sears, et al.. (1987). Predeposited Autologous Blood for Elective Surgery. New England Journal of Medicine. 316(9). 517–520. 227 indexed citations

20.

Ness, Paul M., Toby L. Simon, Christine L. Cole, & Abe Walston. (1974). A pilot study of streptokinase therapy in acute myocardial infarction: observations on complications and relation to trial design. American Heart Journal. 88(6). 705–712. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact